Announced Fri, 24 Jul · 17:49 IST
Strides Pharma Q1FY27 earnings call on July 31, 2026
Board & Shareholder Meetings View source PDF
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹1021.00
prior close
₹1022.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9+1.1+1.4+1.0——————————
Up moveDown movePending
AI summary
Strides Pharma Science has scheduled an earnings call on Friday, July 31, 2026 at 5:00 PM IST to discuss its unaudited financial results for Q1FY27 (quarter ended June 30, 2026). Managing Director and Group CEO Badree Komandur and Group CFO Vikesh Kumar will interact with investors and analysts. Dial-in details for India, USA, Singapore, UK and Hong Kong, along with a pre-registration link, have been shared.
Likely market impact
Investors can hear management discuss Q1FY27 performance on July 31. No direct material impact expected from call invitation itself.